1,730 followers
Our CEO, Nick Sireau, and co-founder, Professor Ranganath, discuss the barriers faced by #RareDisease patient groups to conducting successful clinical trials in their paper published in @OAE_RDODJ 👉https://t.co/2f4CnGE1aJ
Our CEO, Nick Sireau, and co-founder, Professor Ranganath, discuss the barriers faced by #RareDisease patient groups to conducting successful clinical trials in their paper published in @OAE_RDODJ 👉https://t.co/2f4CnGE1aJ
Clinical development innovation in rare diseases: overcoming barriers to successful delivery of a randomised clinical trial in alkaptonuria—a mini-review https://t.co/l6hehMxzjP